Epivir (Lamivudine) - Adverse Event Reports - All Cases - Drug Exposure During Pregnancy

Adverse event in receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-10-19

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias

Suspect drug(s):
Viracept
    Administration route: Oral
    Indication: HIV Infection

Videx

Sustiva

Epivir

Norvir

Retrovir

Indinivir Sulfate

Adverse event in 27 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18

Patient: 27 year old female

Adverse reactions / side effects: Cholestasis of Pregnancy, Drug Exposure During Pregnancy, Proteus Infection, Anogenital Warts, Genital Infection

Suspect drug(s):
Combivir
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2005-02-16

Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Start date: 2004-07-29
    End date: 2005-02-16

Viread
    Dosage: 300mg per day
    Start date: 2004-07-29

Norvir
    Dosage: 400mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Fuzeon
    Dosage: 180mg per day
    Start date: 2005-03-22
    End date: 2005-03-31

Invirase
    Dosage: 2000mg per day
    Start date: 2004-09-29
    End date: 2005-02-16

Adverse event in receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient:

Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Indication: HIV Infection

Retrovir
    Indication: HIV Infection

Epivir
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Retrovir
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Morphine

Viracept
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Adverse event in 28 year old female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-06-25

Patient: 28 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection

Retrovir
    Administration route: Oral
    Indication: HIV Infection

Viracept
    Administration route: Oral
    Indication: HIV Infection

Morphine
    Administration route: Oral

Adverse event in female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: female

Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: ongoing gestational weeks 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Videx
    Dosage: ongoing at gestational weeks 2 through 10
    Indication: HIV Infection
    Start date: 1997-05-29
    End date: 1997-07-01

Fortovase
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Retrovir
    Dosage: initiated at gestational week 10
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Retrovir
    Dosage: infusion at delivery
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Crixivan
    Dosage: ongoing gestational week 2 through 10
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: initiated at gestational week 29
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Epivir
    Dosage: 6 week course after birth
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-07

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Drug Exposure During Pregnancy, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Didanosine
    Dosage: 250 mg, qd, oral
    Administration route: Oral
    Indication: Retroviral Infection
    Start date: 2004-09-01

Norvir
    Dosage: 100 mg/day, oral
    Administration route: Oral
    Indication: Retroviral Infection

Fuzeon
    Dosage: 90 mg, bid, subcutaneous
    Indication: Retroviral Infection

Valganciclovir HCL
    Indication: Cytomegalovirus Test
    Start date: 2004-09-01

Reyataz(atazanvir)
    Dosage: 300 mg/day, oral
    Administration route: Oral
    Indication: Retroviral Infection

Epivir
    Indication: Retroviral Infection

Cotrim
    Indication: Prophylaxis
    Start date: 2004-01-01

Lamivudine
    Dosage: 300 mg/day, oral
    Administration route: Oral

Adverse event in 28 month old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29

Patient: 28 month old female

Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Videx
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Retrovir
    Dosage: from the 13th week to the 26th week of gestation.
    Start date: 1997-10-01
    End date: 1998-01-01

Invirase
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Norvir
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: from the 17th week of gestation to the 26th week.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-11-01
    End date: 1998-01-01

Retrovir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-10-01
    End date: 1998-01-01

Adverse event in male receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-05-09

Patient: male, weighing 2.8 kg (6.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly, Diaphragmatic Hernia, Pregnancy

Suspect drug(s):
Combivir
    Dosage: 900mg per day
    Start date: 2005-02-16

Epivir
    Dosage: 300mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Viread
    Dosage: 300mg per day
    Start date: 2004-07-29

Norvir
    Dosage: 400mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Fuzeon
    Dosage: 180mg per day
    Start date: 2005-03-22
    End date: 2005-03-31

Invirase
    Dosage: 2000mg per day
    Start date: 2004-09-29
    End date: 2005-02-16

Adverse event in 38 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-05-07

Patient: 38 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Induced, Cervical Dysplasia, Ectopic Pregnancy

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-06-01

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-12-21

Other drugs received by patient: Reyataz; Norvir; Viread; Truvada; Invirase

Adverse event in receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03

Patient:

Adverse reactions / side effects: Vertical Infection Transmission, Drug Exposure During Pregnancy, Human Immunodeficiency Virus Transmission, Maternal Condition Affecting Foetus, Failure TO Thrive, Hepatosplenomegaly

Suspect drug(s):
Retrovir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Epivir
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Nevirapine
    Dosage: transplacentary
    Indication: Antiviral Prophylaxis

Quinine Sulfate
    Dosage: transplacentary
    Indication: Plasmodium Falciparum Infection

Adverse event in 32 year old female receiving Epivir (Lamivudine)

Reported by a physician from Botswana on 2007-03-29

Patient: 32 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous, Ectopic Pregnancy

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-02-13

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2004-02-13

Viramune
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2005-03-18

Sustiva
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2004-02-13
    End date: 2005-03-18

Adverse event in receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-27

Patient:

Adverse reactions / side effects: Congenital Hydronephrosis, Drug Exposure During Pregnancy, Normal Delivery

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Indication: HIV Infection
    Start date: 2006-04-20
    End date: 2006-06-24

Combivir
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2006-06-27

Other drugs received by patient: Zerit; Sustiva; Reyataz; Norvir

Adverse event in female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-03-05

Patient: female

Adverse reactions / side effects: Cleft LIP and Palate, Drug Exposure During Pregnancy, Anaemia, Drug Exposure VIA Breast Milk

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Indication: HIV Infection
    Start date: 2004-02-13

Retrovir
    Dosage: 400mg per day
    Indication: HIV Infection
    Start date: 2004-02-13

Viracept
    Dosage: 2500mg per day
    Indication: HIV Infection
    Start date: 2004-02-13

Retrovir
    Dosage: .46ml four times per day
    Administration route: Oral
    Start date: 2004-06-22
    End date: 2004-08-03

Other drugs received by patient: Lopemin; Ferrum; Utemerin

Adverse event in female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from Botswana on 2007-03-01

Patient: female, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Vitiligo, Pregnancy, Umbilical Hernia

Suspect drug(s):
Zerit
    Start date: 2004-06-01
    End date: 2005-04-09

Epivir
    Start date: 2004-06-01
    End date: 2005-04-09

Viramune
    Start date: 2004-06-01
    End date: 2005-04-09

Adverse event in receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from South Africa on 2007-02-21

Patient:

Adverse reactions / side effects: Nose Deformity, Drug Exposure During Pregnancy, Premature Baby, Talipes, Limb Malformation

Suspect drug(s):
Epivir
    Dosage: 150mg per day
    Indication: HIV Infection
    Start date: 2005-02-23

Retrovir
    Dosage: 600mg per day
    Indication: HIV Infection
    Start date: 2005-12-29

Zerit
    Dosage: 80mg per day
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Sustiva
    Dosage: 600mg per day
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Viramune
    Dosage: 400mg per day
    Indication: HIV Infection
    Start date: 2005-12-29

Adverse event in male receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12

Patient: male

Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Retrovir
    Dosage: oral
    Administration route: Oral

Epivir
    Dosage: transplacentary
    Indication: HIV Infection

Stavudine
    Dosage: transplacentary
    Indication: HIV Infection

Nevirapine
    Dosage: transplacentary
    Indication: HIV Infection

Retrovir
    Dosage: transplacentary
    Indication: HIV Infection

Adverse event in receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-09

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Hydronephrosis

Suspect drug(s):
Epivir (Lamivudine)

Other drugs received by patient: Zerit; Sustiva; Reyataz; Norvir

Adverse event in 6 month old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-01-25

Patient: 6 month old male, weighing 2.5 kg (5.5 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Epilepsy

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Retrovir
    Dosage: .38ml per day
    Start date: 2004-09-23
    End date: 2004-09-24

Retrovir
    Administration route: Oral
    Start date: 2004-09-26
    End date: 2004-11-18

Retrovir
    Dosage: .7ml three times per day
    Administration route: Oral
    Start date: 2004-10-26
    End date: 2004-11-18

Epivir
    Dosage: 400mg per day
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Retrovir
    Dosage: 300mg per day
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Viramune
    Start date: 2004-09-22
    End date: 2004-09-23

Viracept
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Viracept
    Dosage: 280mg twice per day
    Administration route: Oral
    Start date: 2004-10-26
    End date: 2004-11-18

Marijuana

Other drugs received by patient: Viramune; Bactrim; Espo; Glucose; Glucose

Adverse event in male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-01-19

Patient: male

Adverse reactions / side effects: Paresis Cranial Nerve, Vomiting, Visual Acuity Reduced, Neoplasm, Somnolence, Strabismus, Papilloedema, Diplopia, Pinealoblastoma, Fatigue, Drug Exposure During Pregnancy, Hydrocephalus

Adverse event resulted in: hospitalization

Suspect drug(s):
Retrovir
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 1998-04-28
    End date: 1998-06-05

Epivir
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 1998-04-28
    End date: 1998-06-05

Other drugs received by patient: Retrovir; Epivir; Retrovir; Clamoxyl

Adverse event in male receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-12

Patient: male

Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias

Suspect drug(s):
Epivir
    Indication: HIV Infection

Retrovir
    Indication: HIV Infection

Viracept
    Indication: HIV Infection

Adverse event in female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-01-09

Patient: female, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Foetal Distress Syndrome, Cardiac Murmur, C-Reactive Protein Increased, Drug Exposure During Pregnancy, Meconium in Amniotic Fluid, Electrocardiogram T Wave Abnormal, Tricuspid Valve Incompetence, Cardiac Hypertrophy

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Indication: Antiviral Prophylaxis
    Start date: 1997-09-01

Rifadin
    Indication: Pulmonary Tuberculosis
    Start date: 1997-07-01

Rimifon
    Indication: Pulmonary Tuberculosis
    Start date: 1997-07-01

Zerit
    Indication: Antiviral Prophylaxis
    Start date: 1997-09-01

Other drugs received by patient: Retrovir; Epivir; Retrovir; Videx; Anti-Tuberculosis Medication

Adverse event in 19 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-08

Patient: 19 year old female

Adverse reactions / side effects: Premature Baby, Drug Exposure During Pregnancy, Anaemia

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-06-05

Retrovir
    Dosage: 1mgkh per day
    Indication: HIV Infection
    Start date: 2006-10-24
    End date: 2006-10-24

Zidovudine
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-06-05

Other drugs received by patient: Kaletra; Viracept; Trimethoprim + Sulfamethoxazole; Macrobid; Clotrimazole Troches; Reglan; Promethazine; Cefazolin